poisar

News

Current market catalysts

Source-attributed headlines with timestamps and links to the companies and crypto markets they mention.

Latest Coverage

Latest Headlines

30 headlines

  1. SEC EDGARSEC EDGAR

    8-K filing — VIP Play, Inc. (VIPZ)

    Filed: 2026-09-04 AccNo: 0001493152-26-041599 Size: 13 MB Item 7.01: Regulation FD Disclosure Item 9.01: Financial Statements and Exhibits

  2. SEC EDGARSEC EDGAR

    8-K filing — VIASAT INC (VSAT)

    Filed: 2026-09-04 AccNo: 0001193125-26-383834 Size: 150 KB Item 5.07: Submission of Matters to a Vote of Security Holders Item 9.01: Financial Statements and Exhibits

  3. SEC EDGARSEC EDGAR

    8-K filing — Nuveen Farmland REIT

    Filed: 2026-09-04 AccNo: 0000930413-26-002844 Size: 1 MB Item 1.01: Entry into a Material Definitive Agreement Item 3.02: Unregistered Sales of Equity Securities Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

  4. SEC EDGARSEC EDGAR

    8-K filing — Cardiff Lexington Corp (CDIX)

    Filed: 2026-09-04 AccNo: 0001683168-26-006974 Size: 1 MB Item 3.03: Material Modifications to Rights of Security Holders Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 9.01: Financial Statements and Exhibits

  5. Zacks Investment ResearchNa

    Will Camzyos' Long-Term Benefits Strengthen BMY's Growth Outlook?

    Bristol Myers Squibb's Camzyos demonstrated durable reductions in LVOT obstruction over five years with 97.4% of patients achieving target gradients. Sales surged 74% year-over-year to $729 million in H1 2026. The company seeks FDA approval for adolescents with a decision expected by September 30, 2026. However, competition is intensifying with Cytokinetics' Myqorzo approved in December 2025 and Edgewise Therapeutics advancing EDG-7500 in clinical trials.

  6. Zacks Investment ResearchNa

    NVIDIA & 2 Profitable Stocks to Buy in September for Big Upside

    As September historically brings market volatility, investors should focus on highly profitable companies with strong net income ratios and earnings growth. Three standout stocks meeting rigorous profitability criteria are NVIDIA (63.7% net margin, 93.3% earnings growth), BrightSpring Health Services (2.6% net margin, 82% earnings growth), and Comfort Systems USA (12.8% net margin, 60.7% earnings growth).

  7. Globenewswire IncNa

    Turlov fordert die FIDE auf, den Kandidaten Wadim Rosenstein wegen eines Sponsorenvertrags mit dem Deutschen Schachbund von der Wahlliste zu streichen

    Timur Turlov has filed a complaint with FIDE's election commission requesting the removal of presidential candidate Wadim Rosenstein from the ballot and suspension of the German Chess Federation's voting rights. Turlov alleges that Rosenstein and his company WR Events signed a major sponsorship deal with the German Chess Federation in August 2026, during the election campaign, which violates FIDE electoral regulations prohibiting valuable benefits to voting federations during elections. The complaint draws parallels to a 2018 case where similar violations resulted in delegate suspension and federation exclusion.

  8. Globenewswire IncRosen Law Firm

    PLNT FINAL DEADLINE: ROSEN, NATIONAL INVESTOR COUNSEL, Encourages Planet Fitness, Inc. Investors with Losses in Excess of $100K to Secure Counsel Before Important September 14 Deadline in Securities Class Action - PLNT

    A securities class action lawsuit has been filed against Planet Fitness, Inc. for allegedly making materially false and misleading statements about customer acquisition and marketing metrics during the Class Period (November 6, 2025 - May 6, 2026). The lawsuit claims Planet Fitness' updated marketing strategy failed to resonate with its target demographic, resulting in significant headwinds in net member joins and rendering fiscal 2026 guidance unachievable. Investors with losses exceeding $100K are encouraged to secure counsel before the September 14, 2026 lead plaintiff deadline.

  9. Globenewswire IncRobbins Llp

    Robbins LLP Reminds CCOI Investors of the Pending Class Action Lawsuit; Harmed Investors Should Contact the Firm for Information About Leading the Class Action Against Cogent Communications Holdings, Inc.

    A securities class action lawsuit has been filed against Cogent Communications Holdings, Inc. (CCOI) for allegedly making false statements about its optical wavelength business backlog and financial capacity. The complaint alleges the company misrepresented customer demand and failed to disclose that most backlog orders were unlikely to convert to paid orders. CCOI's stock has declined over 80% from its Class Period high, with major drops following dividend cuts and weak financial disclosures. Investors have until September 21, 2026, to seek lead plaintiff appointment.

  10. Globenewswire IncNa

    Crane NXT to Participate in the 2026 Jefferies Global Industrial Conference

    Crane NXT, a global leader in authentication and traceability technologies, announced it will participate in the 2026 Jefferies Global Industrial Conference on September 10, 2026. The company's President and CEO Aaron Saak and CFO Christina Cristiano will participate in a fireside chat at 1:30 p.m. Eastern Time, with a live webcast available on the company's website.

  11. The Motley FoolKeithen Drury

    SoundHound's Business Is Booming. Can the $7 Stock Double by September 2027?

    SoundHound AI's stock has fallen from nearly $25 to under $7 per share, but the company's business fundamentals remain strong with 45% year-over-year revenue growth to $62 million in Q2. The company combines AI with speech recognition for restaurant automation and aims to expand into banking, healthcare, and insurance customer service. While the stock is fairly valued at less than 15x sales, its ability to double depends on whether enterprise contracts materialize, making it a high-risk, high-reward investment.

  12. Zacks Investment ResearchNa

    Can BTSG Outgrow the $20B Acute Infusion Market on Volume Growth?

    BrightSpring Health Services (BTSG) reported acute infusion volume growth exceeding 20% year-over-year in Q2, roughly 7-8x the overall infusion market growth rate. The company plans to expand into 12-15 additional states over five years to capitalize on a fragmented $20 billion addressable market. Management is investing in infrastructure, AI-enabled intake, and analytics to support expansion, with the stock up 64% year-to-date and rated as a Zacks Rank #1 Strong Buy.

  13. The Motley FoolJack Delaney

    Elanco Director Purchases 40,000 Shares for $936,000

    Lawrence Erik Kurzius, Director at Elanco Animal Health, purchased 40,000 shares at $23.40 per share on August 20, 2026, expanding his direct holdings by 27%. The insider purchase signals confidence in the company, with analysts showing strong bullish sentiment—89% of 18 analysts rate it a buy with a median 12-month price target of $32, representing potential 31% upside.

  14. Globenewswire IncRobbins Llp

    EQPT Investor Alert - EquipmentShare.com Stockholders with Large Losses Should Contact Robbins LLP for Information About the Securities Fraud Class Action Lawsuit

    A securities class action has been filed against EquipmentShare.com, Inc. (NASDAQ: EQPT) for allegedly making false and misleading statements regarding undisclosed related-party transactions with entities owned or controlled by co-founders. Following a June 24, 2026 report by Umibōzu Research alleging $77+ million in undisclosed payments to founder-affiliated entities, EQPT stock declined over 34.5% from its $24.50 IPO price. Investors who purchased securities between January 23 and June 23, 2026 may be eligible to participate in the class action.

  15. Zacks Investment ResearchNa

    Here's Why You Should Retain Cencora Stock in Your Portfolio for Now

    Cencora's U.S. Healthcare Solutions business demonstrated accelerating momentum with 5% revenue growth and 16% operating income growth in Q3, driven by specialty strength and OneOncology's performance. However, the company faces headwinds from manufacturer list-price reductions, the pending MWI divestiture expected to create a $150 million earnings impact, and regulatory uncertainty around 340B and ASP rules. GLP-1 growth and international operations provide diversification opportunities.

  16. The Motley FoolBrendan Coffey

    Pampa Energía Founder and Chairman Marcos Mindlin Buys 1.3 Million Shares. What Does This Mean for Investors in 2026?

    Pampa Energía founder and chairman Marcos Mindlin purchased approximately 1.3 million shares for $4.3 million, expanding his direct stake by 6% to 21.4 million shares valued at $1.69 billion. The purchase at $3.34 per share, significantly below the market price of $79.24, is viewed as a bullish signal, as insider buying is historically associated with price gains about 60% of the time. Most analysts rate the company a 'buy' with strong exploration and production outlook.

  17. Globenewswire IncNa

    Matinas BioPharma Receives Notice of Non-Compliance with NYSE American Continued Listing Standards

    Matinas BioPharma received a notice from NYSE American on August 31, 2026, stating the company is not in compliance with continued listing standards due to stockholders' equity of $1.8 million (below the required $2.0 million threshold) and losses in five consecutive fiscal years. The company submitted a compliance plan accepted by NYSE American with a deadline of October 2, 2027. Shares will continue trading during the plan period, but delisting proceedings may be initiated if compliance is not achieved.

  18. The Motley FoolAdam Spatacco

    Jensen Huang Said This Word Exactly 1 Time During Nvidia's Earnings Call, and That Was Enough to Put Artificial Intelligence (AI) Bubble Fears to Rest

    Nvidia CEO Jensen Huang's single use of the word 'visibility' during earnings signals the company's unprecedented insight into AI infrastructure demand across land, power, and supply chains. With top hyperscalers expected to spend $800 billion on capex in 2026 and $1.3 trillion in 2027, Nvidia's 70% revenue growth guidance and strategic equity stakes in networking and optical companies position it as the architect of AI factories rather than just a chip vendor, suggesting secular demand rather than a bubble.

  19. Globenewswire IncNa

    Turlov demande à la FIDE de retirer le candidat Wadim Rosenstein du scrutin en raison d’un accord de sponsoring avec la Fédération allemande des échecs

    Timur Turlov has filed a complaint with FIDE's Electoral Commission requesting the removal of presidential candidate Wadim Rosenstein from the ballot and suspension of the German Chess Federation's voting rights. Rosenstein's company WR Events became a major sponsor of the German Chess Federation in August 2026, just weeks before the September 26 election, which Turlov argues violates FIDE electoral rules prohibiting candidates from providing valuable consideration to voting federations during campaigns.

  20. SEC EDGARSEC EDGAR

    8-K filing — CEA Industries Inc. (BNCWW)

    Filed: 2026-09-04 AccNo: 0001482541-26-000045 Size: 2 MB Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year Item 8.01: Other Events Item 9.01: Financial Statements and Exhibits

Source
Source-attributed market-news archive
Observed
Checked
Cadence
Continuous captured-news feed
Status
fresh